For the quarter ended March 2024, Lantheus Holdings (LNTH) reported revenue of $369.98 million, up 23% over the same period last year. EPS came in at $1.69, compared to $1.47 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $349.46 million, representing a surprise of +5.87%. The company delivered an EPS surprise of +9.03%, with the consensus EPS estimate being $1.55.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ...

Lantheus Holdings (LNTH) came out with quarterly earnings of $1.69 per share, beating the Zacks Consensus Estimate of $1.55 per share. This compares to earnings of $1.47 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 9.03%. A quarter ago, it was expected that this diagnostic imaging company would post earnings of $1.48 per share when it actually produced earnings of $1.75, delivering a surprise of 18.24%.Over the last four qu ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36569 LANTHEUS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 35-2318913 (State o ...

Exhibit 99.1 Lantheus Reports First Quarter 2024 Financial Results First Quarter 2024 • Worldwide revenue of $370.0 million, an increase of 23.0% from first quarter 2023 • GAAP fully diluted net income per share of $1.87, compared to GAAP fully diluted net loss per share of $0.04 in first quarter 2023. Adjusted fully diluted net income per share of $1.69 compared to adjusted fully diluted net income per share of $1.47 in the first quarter 2023 • The Company increases full year 2024 net revenue and earnings ...

Lantheus Holdings, Inc. (LNTH) has been gaining from its focus on pipeline development. The optimism, led by a solid fourth-quarter 2023 performance and strength in radiopharmaceuticals, is expected to contribute further. However, dependence upon third parties and macroeconomic concerns are major downsides.Over the past year, the Zacks Rank #3 (Hold) stock has risen 8.5% compared with 3.5% growth of the industry. The S&P 500 has witnessed 7.8% growth in the said time frame.The renowned radiopharmaceutical-f ...

Lantheus Holdings (LNTH) closed the most recent trading day at $65.56, moving +0.55% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 1.02%. Elsewhere, the Dow saw an upswing of 0.4%, while the tech-heavy Nasdaq appreciated by 2.03%.The diagnostic imaging company's stock has climbed by 4.76% in the past month, exceeding the Medical sector's loss of 5.2% and the S&P 500's loss of 3.15%.The upcoming earnings release of Lantheus Holdings will be of great intere ...

Lantheus Holdings, Inc. (LNTH) is scheduled to release first-quarter 2024 results on May 02, before the opening bell.In the last reported quarter, Lantheus’ earnings per share of $1.75 surpassed the Zacks Consensus Estimate by 18.2%. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on all occasions, the average being 14.8%.Let’s see how things have shaped up prior to this announcement.Factors at PlayOn fourth-quarter 2023 earnings call, Lantheus’ management confirmed t ...

Lantheus Holdings (LNTH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Shares of this diagnostic imaging company have returned +9.6% over the past month versus the Zacks S&P 500 composite's -3% change. The Zacks Medical - Products industry, to which Lantheus Holdings belongs, has lost 2.7% over this period. Now the key question is: Where could the stock be headed in the near term?Whi ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Lantheus Holdings (LNTH) , which belongs to the Zacks Medical - Products industry, could be a great candidate to consider.This diagnostic imaging company has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 14.80%.For the last re ...

BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the "Company") (NASDAQ:LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, May 2, 2024, to discuss its financial and operating results for the first quarter of 2024. To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of ...